Tonix Pharmaceuticals (TNXP) Announces Presentation of Encouraging TNX-102 SL Phase 2b Data in Fibromyalgia
Tweet Send to a Friend
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) announced that the company presented results from a retrospective analysis from its Phase 2b ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
